Efinopegdutide

Efinopegdutide is a promising biomedicine designed to target the treatment of obesity and type 2 diabetes. Through its potent agonist activity on the glucagon-like peptide 1 receptor, it promotes weight loss by reducing appetite and increasing feelings of fullness. Additionally, Efinopegdutide improves glycemic control by regulating insulin secretion and glucose metabolism.

Online Inquiry

CAT#R2023
CAS2055640-93-0
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 Figure 1. Chemical structure of pentagastrinPentagastrin, known as peptavlon, is a synthetic pentapeptide that p ...

The hexapeptide-9, a cosmetic peptide  of skin agingSkin aging is the obvious external manifestation of a natural ...

 Deslorelin acetate, marketed under the trade names Ovuplant, SucroMate and Suprelorin, is an injectable gonadotr ...

  PKC (19-36), a synthetic peptide of the pseudosubstrate domain of the kinase, is a selective inhibitor of prote ...

 Delmitide, also known as RDP58, is a novel D-amino acid decapeptide with anti-inflammatory effect. RDP58 is a te ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.